Cognios Beta Neutral Large Cap Fund’s Elevance Health ELV Stock Holding History

Cognios Beta Neutral Large Cap Fund’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$449K	Sell	865 -140	-14%	-$69.6K	0.58%	71
2023 Q4	$474K	Sell	1,005 -122	-11%	-$56.4K	0.62%	75
2023 Q3	$491K	Sell	1,127 -21	-2%	-$9.53K	0.64%	81
2023 Q2	$510K	Sell	1,148 -169	-13%	-$78K	0.59%	89
2023 Q1	$605K	Buy	+1,317	New	+$627K	0.58%	89

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Cognios Beta Neutral Large Cap Fund's ELV Position: Q1 2024 in Review

Cognios Beta Neutral Large Cap Fund reduced its Elevance Health (ELV) stake by 14% in Q1 2024, selling an estimated $69.6K and leaving 865 shares worth $449K. The position accounts for 0.58% of the portfolio, ranked #71.

Cognios Beta Neutral Large Cap Fund first reported a position in ELV in Q1 2023 and has held it in 5 quarters since. The position peaked at $605K in Q1 2023. 1,667 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

Cognios Beta Neutral Large Cap Fund held 865 shares of Elevance Health worth $449K as of Q1 2024.
Cognios Beta Neutral Large Cap Fund sold 140 Elevance Health shares in Q1 2024, an estimated $69.6K.
Elevance Health made up 0.58% of Cognios Beta Neutral Large Cap Fund's portfolio in Q1 2024, its #71 holding.
Cognios Beta Neutral Large Cap Fund first reported a position in Elevance Health in Q1 2023 and has held it in 5 quarters since.
Cognios Beta Neutral Large Cap Fund's Elevance Health position peaked at $605K in Q1 2023.
1,667 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on Cognios Beta Neutral Large Cap Fund's 13F filing for Q1 2024, filed 8 May 2024.